| MolName | (5Z)-3-cyclohexyl-5-[[2-[2-(2-hydroxyethoxy)ethylamino]-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one |
| MolecularFormula | C22H26N4O4S2 |
| Smiles | OCCOCCNC(N=C1N2C=CC=C1)=C(/C=C(/C(N1C3CCCCC3)=O)\SC1=S)C2=O |
| InChI | InChI=1S/C22H26N4O4S2/c27-11-13-30-12-9-23-19-16(20(28)25-10-5-4-8-18(25)24-19)14-17-21(29)26(22(31)32-17)15-6-2-1-3-7-15/h4-5,8,10,14-15,23,27H,1-3,6-7,9,11-13H2 |
| InChIK | HXKUCCGZNCBCRD-UHFFFAOYSA-N |
| TotalMolweight | 474.604 |
| Molweight | 474.604 |
| MonoisotopicMass | 474.139546 |
| CLogP | 0.2076 |
| CLogS | -4.74 |
| H Acceptors | 8 |
| H Donors | 2 |
| TotalSurfaceArea | 353.55 |
| Relative PSA | 0.35282 |
| PolarSurfaceArea | 151.86 |
| Druglikeness | -3.2165 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | low |
| Nasty Functions | polar activated DB |
| Shape Index | 0.53125 |
| Fragments | 1 |
| Non HAtoms | 32 |
| NonCHAtoms | 10 |
| Electronegative Atoms | 10 |
| Rotatable Bond | 8 |
| Rings Closures | 4 |
| Small Rings | 4 |
| Sp3Atoms | 14 |
| Symmetricatoms | 2 |
| Amides | 2 |
| BasicNitrogens | 1 |
| StereoCon |
Click to Load Molecule:
1 - (5Z)-3-cyclohexyl-5-[[2-[2-(2-hydroxyethoxy)ethylamino]-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one | 2 - (5Z)-3-cyclohexyl-5-[[2-[2-(2-hydroxyethoxy)ethylamino]-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one